Position in NKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$106,798
+$62,583 QoQ
Shares Held
37,738
+80.1% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 136 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. NKTX ranks #286 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in NKTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $106,798 | 37,738 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $44,215 | 20,955 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $88,794 | 47,997 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $68,140 | 32,918 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $56,974 | 34,322 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $58,436 | 31,759 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $77,329 | 31,056 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $109,804 | 24,293 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $138,577 | 23,448 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $117,666 | 10,885 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $62,792 | 9,514 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $10,749 | 7,734 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $39,303 | 17,947 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $45,738 | 12,884 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $94,821 | 15,830 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $386,297 | 29,354 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $198,992 | 16,152 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $36,985 | 3,250 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $97,333 | 6,341 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $223,369 | 8,032 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $254,533 | 8,032 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $191,642 | 5,825 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $920,635 | 14,977 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $375,298 | 12,485 | Shares | Defined | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||